Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Nature Communications 7 Article number:12336 (2016); Published 22 August 2016; Updated 29 September 2016 Arthur E. Frankel, who helped to interpret the clinical relevance of the findings, was inadvertently omitted from the authors list during the final stages of production. This has now been correct...
Guardado en:
Autores principales: | Ugur Eskiocak, Vijayashree Ramesh, Jennifer G. Gill, Zhiyu Zhao, Stacy W. Yuan, Meng Wang, Travis Vandergriff, Mark Shackleton, Elsa Quintana, Arthur E. Frankel, Timothy M. Johnson, Ralph J. DeBerardinis, Sean J. Morrison |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a457b2620e964011be0bf95dd1a7332b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
por: Ugur Eskiocak, et al.
Publicado: (2016) -
Synergistic effect of cold atmospheric pressure plasma and free or liposomal doxorubicin on melanoma cells
por: Konstantina Pefani-Antimisiari, et al.
Publicado: (2021) -
Arginine deprivation therapy for malignant melanoma
por: Yoon JK, et al.
Publicado: (2012) -
Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma
por: Harish Potu, et al.
Publicado: (2017) -
Genomic regression analysis of coordinated expression
por: Ling Cai, et al.
Publicado: (2017)